secwatch / observer
8-K filed October 5, 2023, 7:59 PM ET ticker QURE CIK 0001590560
other material confidence high sentiment negative materiality 0.75

uniQure N.V. (QURE): restructuring charge — uniQure cuts 28% of workforce, discontinues over half of R&D projects to extend cash runway to Q2 2027

uniQure N.V.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ricardo Dolmetsch

Chief Scientific Officer
QURE · uniQure N.V.
Effective
2023-10-04
Successor
Richard Porter
Filed
October 5, 2023, 7:59 PM ET
On October 5, 2023, the Company announced that, effective October 4, 2023 (the “Effective Date”), Ricardo Dolmetsch terminated his employment with the Company as its Chief Scientific Officer for Good Reason
Role change

Richard Porter

Chief Business and Scientific Officer
QURE · uniQure N.V.
Effective
2023-10-05
Filed
October 5, 2023, 7:59 PM ET
the Board of Directors of the Company have designated Richard Porter, the Company’s current Chief Business Officer, to serve as the Company’s Chief Business and Scientific Officer, effective as of October 5, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ricardo Dolmetsch was terminated as Chief Scientific Officer at uniQure N.V..

Action
terminated
Role
Chief Scientific Officer
Exact text from the filing
On October 5, 2023, the Company announced that, effective October 4, 2023 (the “Effective Date”), Ricardo Dolmetsch terminated his employment with the Company as its Chief Scientific Officer for Good Reason
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Richard Porter changed role as Chief Business and Scientific Officer at uniQure N.V..

Action
designated
Role
Chief Business and Scientific Officer
Exact text from the filing
the Board of Directors of the Company have designated Richard Porter, the Company’s current Chief Business Officer, to serve as the Company’s Chief Business and Scientific Officer, effective as of October 5, 2023.
View on SEC.gov
Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

uniQure N.V. announced a restructuring with charges of approximately $2.3 million affecting global workforce and research operations (approximately 28% of the Company’s global workforce).

Type
restructuring
Charge
approximately $2.3 million
Affected area
global workforce and research operations
Headcount
approximately 28% of the Company’s global workforce
Exact text from the filing
The Plan includes the discontinuation of more than half of the Company’s research and technology projects, the elimination of approximately 28% of the Company’s global workforce and the closure of a research lab in Lexington, MA. The Company estimates that it will incur charges of approximately $2.3 million in connection with the Plan, consisting primarily of cash expenditures related to employee severance costs.
View on SEC.gov

Browse all restructurings & charges →

uniQure N.V. filing history →

Source: SEC EDGAR
accession 0001104659-23-107209
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.